Recently, clinical data from several clinical research centers have shown that the single nucleotide polymorphisms (SNPs) of HSD17B13, especially those of the rs72613567: TA allele, were associated with the progression and severity of NAFLD [11,22,23,24]. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.